COMPARISON OF U-73,975 AND CISPLATIN CYTOTOXICITY IN FRESH CERVICAL AND OVARIAN-CARCINOMA SPECIMENS WITH THE ATP-CHEMOSENSITIVITY ASSAY

被引:11
作者
HIGHTOWER, RD
SEVIN, BU
PERRAS, JP
UNTCH, M
ANGIOLI, R
RAMOS, R
AVERETTE, H
机构
[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami School of Medicine, Miami
关键词
D O I
10.1016/0090-8258(92)90104-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
U-73,975 (U-73), a closely related synthetic analogue of the antitumor agent CC-1065, acts by binding tightly in the minor groove of DNA. A comparison was made between the cytotoxicity of U-73 and cisplatin (DDP) on 11 fresh cervical and 7 fresh ovarian carcinoma specimens. The ATP-chemosensitivity assay as previously described (Sevin et al. Gynecol. Oncol. 31, 191-204, 1988) was used to determine the cytotoxic effect of U-73 and DDP. IC 50s were calculated using regression analysis. The mean IC 50s for U-73 and DDP were 519 pg/ml and 2918 ng/ml, respectively, for the cervical carcinoma specimens and 324 pg/ml and 2649 ng/ml, respectively, for the ovarian carcinoma specimens. Significance comparing U-73 and DDP for cervical and ovarian tissue was demonstrated with P < 0.001. U-73 was 4000 times as cytotoxic per unit of mass as DDP on cervical carcinoma compared to over 8000 times for ovarian carcinoma. Based on these in vitro data, U-73 appears to be a very promising antitumor agent for cervical and ovarian carcinoma. © 1992.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 22 条
[1]  
ALBERTS DS, 1980, HUMAN TUMOR STEM CEL, P351
[2]   THE STRUCTURE OF CC-1065, A POTENT ANTI-TUMOR AGENT, AND ITS BINDING TO DNA [J].
CHIDESTER, CG ;
KRUEGER, WC ;
MIZSAK, SA ;
DUCHAMP, DJ ;
MARTIN, DG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (25) :7629-7635
[3]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[4]  
DEKONING T F, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P491
[5]  
DEKONING T F, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P348
[6]  
DEKONING TF, 1987, P AM ASSOC CANC RES, V28, P262
[7]  
DEPPE G, 1990, CHEMOTHERAPY GYNECOL, P127
[8]  
DISAIA PJ, 1989, CLIN GYNECOLOGIC ONC, P115
[9]   CC-1065 (NSC-298223), A NEW ANTI-TUMOR ANTIBIOTIC PRODUCTION, INVITRO BIOLOGICAL-ACTIVITY, MICROBIOLOGICAL ASSAYS AND TAXONOMY OF PRODUCING MICROORGANISM [J].
HANKA, LJ ;
DIETZ, A ;
GERPHEIDE, SA ;
KUENTZEL, SL ;
MARTIN, DG .
JOURNAL OF ANTIBIOTICS, 1978, 31 (12) :1211-1217
[10]   SEQUENCE SPECIFICITY OF DNA ALKYLATION BY THE UNNATURAL ENANTIOMER OF CC-1065 AND ITS SYNTHETIC ANALOGS [J].
HURLEY, LH ;
WARPEHOSKI, MA ;
LEE, CS ;
MCGOVREN, JP ;
SCAHILL, TA ;
KELLY, RC ;
MITCHELL, MA ;
WICNIENSKI, NA ;
GEBHARD, I ;
JOHNSON, PD ;
BRADFORD, VS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (12) :4633-4649